Stocks and Investing
Stocks and Investing
Tue, January 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Saxon Maintained (XRAY) at Strong Buy with Increased Target to $42 on, Jan 9th, 2024
David Saxon of Needham, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Strong Buy with Increased Target from $35 to $42 on, Jan 9th, 2024.
David has made no other calls on XRAY in the last 4 months.
There are 6 other peers that have a rating on XRAY. Out of the 6 peers that are also analyzing XRAY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jonathan Block of "Stifel" Maintained at Hold with Decreased Target to $32 on, Monday, November 13th, 2023
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $36 on, Tuesday, November 7th, 2023
- Jason Bednar of "Piper Sandler" Maintained at Hold with Decreased Target to $39 on, Friday, September 22nd, 2023
These are the ratings of the 3 analyists that currently disagree with David
- Brandon Vazquez of "William Blair" Upgraded from Hold to Buy on, Friday, November 10th, 2023
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Friday, November 3rd, 2023
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $41 on, Friday, November 3rd, 2023
Contributing Sources